Valuation: Philadelphia Pharmaceuticals Company

Market Cap 13.8M 19.48M 16.68M 15.61M 14.29M 26.82M 1.86B 27.17M 184M 71.93M 936M 73.14M 71.55M 3.1B P/E 2024
13.7x
P/E 2025 11.9x
Enterprise Value 13.73M 19.38M 16.6M 15.53M 14.22M 26.69M 1.85B 27.04M 184M 71.57M 932M 72.78M 71.19M 3.08B EV / Sales 2024
1.32x
EV / Sales 2025 1.3x
Free-Float
7.27%
Yield 2024
4.67%
Yield 2025 -
1 day-7.07%
1 week-7.07%
Current month-8.00%
1 month-8.00%
3 months+6.98%
6 months+18.71%
Current year+15.00%
1 week 1.84
Extreme 1.84
1.87
1 month 1.84
Extreme 1.84
2.01
Current year 1.5
Extreme 1.5
2.01
1 year 1.48
Extreme 1.48
2.01
3 years 1.36
Extreme 1.36
2.01
5 years 1.28
Extreme 1.28
2.01
10 years 1.28
Extreme 1.28
3.19
Manager TitleAgeSince
Chief Executive Officer 44 31/12/2012
Chief Tech/Sci/R&D Officer - -
Director of Finance/CFO 50 31/12/2001
Director TitleAgeSince
Chairman 58 -
Director/Board Member 61 31/08/2016
Director/Board Member 64 31/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
-7.07%-7.07%+26.03%+29.58% 19.48M
-0.08%-1.43%+15.87%+67.24% 47.71B
-3.21%+1.37%+51.19%+124.26% 40.3B
-0.40%-1.23%-10.08%+17.30% 12.09B
+1.11%-1.34%+13.27%+72.07% 11.68B
+0.19%+0.58%+30.98%+151.21% 9.19B
-0.39%-0.92%+20.49%+39.85% 7.57B
-1.35%+0.74%+47.38%-12.13% 7.24B
-0.64%-0.02%+19.65%+205.39% 6.84B
-5.36%-6.36%-38.04%+19.49% 5.42B
Average -1.72%-1.80%+17.67%+71.42% 14.81B
Weighted average by Cap. -1.15%-0.57%+24.08%+83.62%

Financials

2024 2025
Net sales 8.76M 12.37M 10.59M 9.91M 9.07M 17.03M 1.18B 17.25M 117M 45.67M 594M 46.44M 45.43M 1.97B 9.17M 12.94M 11.09M 10.37M 9.49M 17.82M 1.24B 18.05M 123M 47.79M 622M 48.59M 47.54M 2.06B
Net income 822K 1.16M 993K 929K 851K 1.6M 111M 1.62M 10.98M 4.28M 55.73M 4.35M 4.26M 184M 1.01M 1.42M 1.22M 1.14M 1.04M 1.95M 136M 1.98M 13.43M 5.24M 68.19M 5.33M 5.21M 226M
Net Debt 334K 471K 403K 377K 345K 648K 45.05M 657K 4.46M 1.74M 22.63M 1.77M 1.73M 74.86M -67.69K -95.53K -81.83K -76.57K -70.09K -132K -9.14M -133K -905K -353K -4.59M -359K -351K -15.19M
Logo Philadelphia Pharmaceuticals Company
Philadelphia Pharmaceuticals Industry Company PSC is a Jordan-based company that is engaged in the development, manufacture and marketing of human pharmaceutical products of different therapeutic categories. The Company, through its production facilities and laboratories located in Amman Industrial state, develops and produces a number of products that includes: Semisolid Dosage Forms, such as creams, ointments, lotions, gels and suppositories, as well as Liquid Dosage Forms, which include syrups, suspensions, solutions, nasal, drops, mouth washes and vaginal douches. Furthermore, the Company undertakes the distribution and marketing of a range of healthcare systems, miscellaneous and pharmaceuticals of different international brand names, including alimentary, gastrointestinal systems and respiratory systems. The Company markets its products to the local markets and exports to more than 10 countries in the Middle East and North Africa region.
Employees
129
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. PHIL Stock